Back to Glossary
Administration Definition

Half-Life

Also known as: Elimination half-life, Plasma half-life, t½

Half-Life is the time required for the concentration of a substance in the body to decrease by half. In peptide research, half-life determines dosing frequency and is a critical factor in drug design. Longer half-lives allow for less frequent dosing.

Last updated: February 1, 2026

How Half-Life Works

When a peptide enters the body, it begins to be broken down and eliminated through various mechanisms:

  1. Enzymatic degradation - Enzymes like DPP-4 break down peptides
  2. Renal clearance - Kidneys filter and excrete peptide fragments
  3. Hepatic metabolism - Liver processes and clears substances
  4. Receptor-mediated endocytosis - Cells internalize and degrade bound peptides

Why Half-Life Matters

Half-life directly impacts:

FactorShort Half-LifeLong Half-Life
Dosing frequencyMultiple times dailyWeekly or less
Blood level stabilityMore fluctuationSteadier levels
Side effect managementFaster resolutionLonger duration
Patient complianceMore challengingEasier

Half-Life Examples in Peptides

Natural GLP-1

  • Half-life: 1-2 minutes
  • Reason: Rapidly degraded by DPP-4 enzyme
  • Clinical impact: Not useful as a medication in natural form

Semaglutide

  • Half-life: ~7 days (168 hours)
  • Reason: Modified structure resists DPP-4, binds to albumin
  • Clinical impact: Once-weekly dosing possible

BPC-157

  • Half-life: Estimated 4-6 hours
  • Reason: Relatively stable peptide structure
  • Clinical impact: Typically dosed 1-2 times daily in research

Factors Affecting Half-Life

Molecular Modifications

  • Fatty acid chains - Adding lipid groups (like in semaglutide) extends half-life by enabling albumin binding
  • PEGylation - Attaching polyethylene glycol increases molecular size and reduces clearance
  • Amino acid substitutions - Replacing susceptible amino acids prevents enzymatic breakdown

Individual Factors

  • Kidney and liver function
  • Body composition
  • Age and metabolism
  • Concurrent medications

Frequently Asked Questions

What does a 7-day half-life mean?

If a peptide has a 7-day half-life, after one week approximately 50% of the original dose remains. After two weeks, 25% remains. After three weeks, 12.5% remains, and so on.

Why do some peptides need daily dosing while others are weekly?

This depends on their half-life. Peptides with short half-lives (hours) need frequent dosing to maintain therapeutic levels. Those with long half-lives (days) can be dosed less frequently. Molecular modifications can dramatically extend half-life.

Is a longer half-life always better?

Not necessarily. Longer half-lives mean side effects also persist longer and there’s less flexibility in dose adjustments. The ideal half-life depends on the specific therapeutic application.

Related Peptides

Related Terms

Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.